<DOC>
	<DOC>NCT01591889</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Roxane Laboratories' Tinidazole 500 mg Tablet under fed conditions.</brief_summary>
	<brief_title>Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions</brief_title>
	<detailed_description />
	<mesh_term>Trichomonas Infections</mesh_term>
	<mesh_term>Tinidazole</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to tinidazole or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>